RAAP Urges Virginia Legislators to Thoroughly Study PDAB Bill Before Action #United_States #Virginia #PDAB #Rare_Access_Action_Project
0
0
0
0
#pdab
Latest posts tagged with #pdab on Bluesky
Trending
Posts tagged #pdab
Recorded a segment on #PDAB and how a #UPL can impact access to medicine for Patients Rising! Can’t wait to see how it turned out!
0
0
0
0
A green background with a white border. White text at the top says: 2025 Annual Report Below text says: The board voted to approve the 2025 Annual Report for the Oregon Legislature. The report outlines the board's activities, price trend analyses, and policy recommendations to improve drug affordability across Oregon. To the right is a screenshot of the yellow report cover with a photo of a family.
A green background with a white border. White text at the top says: 2025 Affordability Reviews. Below text says: Board members identified several top priority drugs that present significant affordability challenges for Oregonians: Cosentyx Creon Vraylar Trulicity Lantus SoloStar Their final vote will be at their January 21 meeting. Icons of an injection, pills, and a price tag with three dollar signs.
A green background with a white border. White text at the top says: Next Year. Below text says: The board is already preparing for 2026 affordability reviews, developing a preliminary list of 137 drug products for review based on 2024 data. To ensure patient voices are heard, a major outreach project will launch in spring of 2026 with community meetings in Salem, Redmond, Portland, and Beaverton, and online. An icon of the state of Oregon with hands raised inside. A speech bubble coming from the state with a pill bottle and a price tag with three dollar signs.
A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: January 21, 2026 at 8 am, Register for Zoom Link. Board members will vote on the final list of unaffordable drugs from their 2025 affordability reviews. A white icon of a calendar with the date January 21.
This Wednesday the #Oregon #PDAB met. Here are the highlights:
- Annual Report
- 2025 #Affordability Reviews
- Next Year's Plan
Next meeting: Jan 21, 2026 at 8 am. Zoom link at dfr.oregon.gov/pdab
#Cosentyx #Creon #Vraylar #Trulicity #LantusSoloStar #HealthPolicy
3
0
0
0
A light green background. At the top white text says: What is an Upper Payment Limit? Below that a white box with black text says: An upper payment limit (UPL) is a price cap for unaffordable prescription drugs that are identified by a regulatory board (like the PDAB). On the right of the white box is a speedometer icon with a dollar sign in the middle. Below that white text says: Will UPLs Lower Drug Prices? Below that a white box with black text says: Yes! This October Colorado’s PDAB became the first to set a UPL on a prescription drug and it’s projected to save them millions of dollars. To the right of the box there is an icon of paper with a dollar sign and a down arrow.
Earlier this month we heard from experts in Maryland and Colorado about how their states are working to save patients money on prescription medications through Upper Payment Limits. Here's our quick summary! Stay tuned for more information!
#UPL #UpperPaymentLimit #PDAB #RXDrugPrices
1
0
0
0
A green background with a white border. White text at the top says: Leadership Changes. Below text says: Vice Chair Dr. Amy Burns resigned effective November 16. Dr. Dan Hartung was elected the new Vice Chair of the Oregon PDAB and began serving immediately. A white icon of a turning gear with icons of people inside
A green background with a white border. White text at the top says: Annual Report. Below text says: Board members reviewed and discussed the Draft 2025 Annual Report. Board members asked why some data columns did not add up. Staff and analysts explained these variances are due to the requirement that insurance carriers submit the top drugs for each segment (and they don’t always overlap) The board agreed to add clarifying statements to the report to acknowledge that. A white icon of a report on a clipboard with a calculator
A green background with a white border. White text at the top says: Policy Recommendations Below text says: The board voted to recommend these policies to Oregon lawmakers: ✓ PBM transparency reforms ✓ “Any-willing-provider” pharmacy access ✓ Permanent CAT tax exemption for pharmacies ✓ Single statewide PBM for Medicaid ✓ Uniform Medicaid Preferred Drug List ✓ Study on Medicaid pharmacy carve-out ✓ New affordability tools (cost-plus, POS rebates) ✓ Expanded PDAB scope ✓ Updated confidentiality rules for trade-secret info
A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: December 17, 2025 at 8 am, Board members will come prepared to nominate specific drugs that they believe present affordability challenges. A white icon of a calendar with the date December 17 is to the right. On the line below a white icon of a calendar that says December 4, and white text that says: Annual Drug Price Transparency hearing on December 4, 2025 at 1:30 pm. Oregonians are encouraged to share their prescription drug story before or during the hearing at: dcbspage.org/RXSTORIES
Wednesday the #Oregon #PDAB met. Highlights include:
- Leadership changes
- Annual report data
- Policy recommendations
Next meeting is Dec. 17, 2025 at 8 am.
We'll keep you posted! #HealthPolicySky #ORPol
1
0
0
0
Great news coming out of Maryland! We're excited to see them move closer to a #PriceCap on some of the most expensive prescription drugs.
Lots of great advocacy by our friends at @mdhealthcareforall.bsky.social
marylandmatters.org/2025/11/17/m...
#Oregon #UpperPaymentLimit #PDAB #HealthPolicySky
5
1
0
0
We know that #Oregon can follow Colorado's lead. Let’s strengthen our #PDAB so it can finally put #patients (not profits) first. (2/2)
www.streetroots.org/news/2025/11...
#RXDrugPrices #HealthPolicySky
0
0
0
0
#Oregon’s #PDAB was built to lower #RXDrug prices, but power interests and the industry's murky pricing systems are keeping it from doing its job. Meanwhile, states like Colorado are proving that real #reform IS possible. (1/2)
www.streetroots.org/news/2025/11...
#HealthPolicySky
0
0
1
0
Why are Price Cap Proposals on Medicines Dangerous to Pharmacies and Patients?
adapadvocacyassociation.blogspot.com/2025/10/why-are-price-ca... #MFP #PDAB via Partnership For Safe Medicines
0
0
0
0
Why are Price Cap Proposals on Medicines Dangerous to Pharmacies and Patients?
adapadvocacyassociation.blogspot.com/2025/10/why-are-price-ca... #MFP #PDAB via Partnership For Safe Medicines
0
0
0
0
Great insight into what states are doing to lower prescription costs for patients— including setting price caps or Upper Payment Limits!
stateline.org/2025/10/30/d...
#RXDrugCost #PDAB #UPL #HealthPolicySky
0
0
0
0
Read our latest blog, "Why are Price Cap Proposals on Medicines Dangerous to Pharmacies and Patients?" adapadvocacyassociation.blogspot.com/2025/10/why-are-price-ca... #MFP #PDAB via Partnership For Safe Medicines
0
0
0
0
Why are Price Cap Proposals on Medicines Dangerous to Pharmacies and Patients?
adapadvocacyassociation.blogspot.com/2025/10/why-are-price-ca... #MFP #PDAB via Partnership For Safe Medicines
0
0
0
0
Prescription drugs aren't #accessible if people can't afford them!
#HealthPolicySky #PrescriptionDrugs #ORPol #Oregon #PDAB
0
0
0
0
A green background with a white border. White text at the top says: New Leadership. Below text says: Michele Koder was appointed as a new board member, bringing pharmacy and Medicaid expertise. A picture of a blond woman in a blue shirt is to the right. In the next line, a picture of a woman with short dark hair and white text that says: Sarah Young joined as Executive Director—a leader in rural health policy and drug price transparency.
A green background with a white border. White text at the top says: Policy Discussion. White text below says: The board discussed legislative policy recommendations to be voted on in November.Highlights included: Pharmacy Benefit Manager (PBM) Reform Auditing the 340B Program PDAB’s role and future Exploring authority to set Upper Payment Limits (UPLs). To the right there are two white line icons, one with a legislative policy with a pill and the other shows three pills.
A green background with a white border. White text at the top says: Affordability Reviews. Below white text says: Reviewed seven insulin glargine products (an essential diabetes medication) Found data errors and outdated pricing info. Noted impact of Oregon’s $35 insulin co-pay cap that reduced costs for patients, but not overall system spending. Work to refine access and equity metrics for affordability reviews.
A green background with a white border. White text at the top says: Looking Ahead. White text below says: Next PDAB Meeting: November 19, 2025 at 8 am, PDAB will review a draft of their Legislative Report due in December. A white icon of a calendar with the date November 19 is to the right. On the line below a white icon of a calendar that says December 4, and white text that says: Annual Drug Price Transparency hearing on December 4, 2025 at 1:30 pm. Oregonians are encouraged to share their prescription drug story before or during the hearing at: dcbspage.org/RXSTORIES
Yesterday the #Oregon #PDAB met. Highlights include:
- New leadership
- Public comments
- Policy conversations
- Insulin affordability reviews
Next meeting is Nov. 19, 2025 at 8 am.
We'll keep you posted! #HealthPolicySky #ORPol
1
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a lime green box with a purple insulin pen icon and white text reads Toujeo Max Solostar or Toujeo SoloStar Generic: None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #ToujeoMaxSolostar or #ToujeoSoloStar?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregonians & they need to hear from YOU! Next meeting: Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a teal box with an indigo insulin vial icon and white text reads Semglee-yfgn Generic: Insulin Gargine-yfgn Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Semglee-yfgn?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes #OCAP
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: Lantus SoloStar or Lantus a dark purple box with a lavendar insulin vial icon, lavendar insulin pen icon and white text reads Lantus SoloStar or Lantus Generic: None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #LantusSoloStar or #Lantus?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a purple box with a teal insulin vial icon and white text reads Insulin Glargine-yfgn Generic of Semglee None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #InsulinGlargine-yfgn?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 @ 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes #OCAP
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a teal box with a yellow-green insulin pen icon and white text reads Basaglar KwikPen Generic: None Therapy Class: Insulin. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #BasaglarKwikPen?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Oct 15 at 8 am.
Comment at: bit.ly/or-pdab-comment
#HealthPolicySky #Insulin #Diabetes #OCAP
0
1
0
0
Looking ahead: Next #Oregon #PDAB Meeting Oct. 15 @ 8am
Affordability Reviews on #insulin:
#BasaglarKwikPen
#InsulinGlardine-yfgn
#Lantus
#LantusSolorStar
#Semglee-yfgn
#ToujeoMaxSolarStar
#ToujeoSoloStar
#HealthPolicySky
0
0
0
0
Green background, white border, white text says Program Updates Sarah Young will be the new Executive Director of PDAB + Drug Price Transparency Program. Michelle Coder (Mount Loma Health) selected to join the board; first meeting Oct. 15, pending Senate confirmation. Dr. Dan Hartung, Dr. Chris Layman & Dan Kennedy reappointed through Dec. 2029. 9th Circuit upheld OR’s HB 4005 drug price transparency law, affirming state authority to collect price increase data (critical for PDAB’s work). Icon of a gavel
Green background, white border, white text says Draft Policy Ideas PDAB past wins: capped insulin at $35/month, made PBMs report more data. New Ideas: One PBM for Medicaid → lower costs and better access Change PBM payment system → more transparency Audit 340B program → more transparency OHA expert may present on the Array RX system. Discussion about how studying the entire drug delivery system might mean adding new voices to the board. Staff will compile ideas for next month. Icon of two speech bubbles
Green background, white border, white text says Affordability Reviews Jardiance: Approved in 2014, patent ends 2026 On Medicare price negotiation list starting 2026 Price has gone up ~5% each year since 2018 PDAB noted payers get big discounts (≈60%) Mounjaro: Approved in 2022, patents run into the 2030s Not on Medicare price list Price rising ~5% per year PDAB discussed patient struggles with insurance coverage leading to treatment gaps Ozempic: Approved in 2017, patents expire 2025–2028 On Medicare price list starting 2027 Price rising ~5% per year PDAB questioned a sudden 2020–21 price dip and noted pharmacies sometimes paying above list price Icon of a prescription drug bottle with two pills on the outside
Green background, white border, white text says Affordability Reviews Rybelsus: Approved in 2017, patents through 2039 On Medicare price list starting 2027 Price rising ~5% per year PDAB flagged strict use instructions (empty stomach, specific water, wait time) as a barrier for patients Trulicity: Approved in 2014, no active patents Not on Medicare price list Price has barely risen (~0.6% per year) PDAB noted Medicare patients may still pay more than others Overall, PDAB heard from staff and providers that transparency remains limited in 340B reporting, with many declining to share payment data.
On Friday the #Oregon #PDAB met. Here are the Highlights:
➡️New executive director and board member
➡️Draft policy ideas
➡️Discussions about the cost Oregonians pay for #Jardiance, #Mounjaro, #Ozempic, #Rybelsus, #Trulicity
➡️ Final comments for affordability reviews by Oct 15
#HealthPolicySky
0
0
1
0
A red rectangle at the top of the page with a white icon of a calendar with a clock and text that says PdAB public comments are due on Monday Sept. 15 at 8 am! Below is a light blue icon of a paper with a dollar sign and a down arrow. White background with black text says The Oregon Prescription Drug Affordability Board (PDAB) is reviewing these drugs to determine if they strain Oregon patients or our health care system at their September 17 meeting. If you or someone you know has taken: Jardiance (Empagliflozin) Mounjaro (Tirzepatide) Ozempic (Semaglutide) Rybelsus (Semaglutide) Trulicity (Dulaglutide) Consider sharing your experience with the Oregon PDAB at the link below. bit.ly/or-pdab-comment
Reminder to submit public comment to the next Oregon Prescription Drug Affordability Board (PDAB) meeting before Monday at 8 am!
Link to submit comments: bit.ly/or-pdab-comment
#Oregon #PDAB #PrescriptionDrugAffordability #Jardiance #Mounjaro #Ozempic #Rybelsus
#Trulicity #PublicComment
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark purple box with a syringe with lime green liquid and white text reads Trulicity Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Trulicity?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark blue box with a yellow pill bottle and white text reads Rybelsus Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Rybelsus?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a purple box with a syringe filled with pink liquid and white text reads Mounjaro Generic: No longer available Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Mounjaro? The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark teal box with a syringe with red liquid and white text reads Ozempic Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Ozempic?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am. Comment at: bit.ly/or-pdab-comment #Antidiabetic #Diabetes #HealthPolicySky
0
0
0
0
Pale yellow background, black text reads Have you or someone you know paid a high price for: a dark teal box with a yellow pill bottle and white text reads Jardiance Generic: None Therapy Class: Antidiabetics. Below the box black text reads Consider sharing your story with the Oregon Prescription Drug Affordability Board
Have you or someone you know paid a high price for #Jardiance?
The #Oregon #PDAB is reviewing high-cost drugs that may strain Oregon patients & they need to hear from YOU! The next meeting is Sept 17 at 8 am.
Comment at: bit.ly/or-pdab-comment
#Antidiabetic #Diabetes #HealthPolicySky
0
0
0
0
Life saving medication shouldn't cost your life savings!
#orpol #Oregon #PDAB #prescriptiondrugcost #OCAP
0
0
0
0